Keystone Dental and Southern Implants Agree to Merge
BURLINGTON, Mass. and IRVINE, Calif., June 21, 2012 /PRNewswire via 
COMTEX/ --
Keystone Dental, Inc. ("Keystone" or "the company"), a leading oral 
healthcare company dedicated to the delivery of breakthrough implant 
technology, and Southern Implants, Inc. ("Southern Implants"), a 
producer of unique and innovative dental implant technologies aimed to 
simplify clinical challenges for implant surgeons and restorative 
dentists, today announced the companies have merged.  The terms of the 
merger agreement were undisclosed.
                                
Both Keystone and Southern Implants are well-known, leading providers of
 dental implant technologies and services, and deeply rooted within the 
oral healthcare community.  With over 25 years of combined experience, 
the merged company becomes one of the largest and most specialized oral 
healthcare providers in the U.S. and is well-positioned to take 
advantage of the expanding dental implant market, particularly in North 
America.  The combined entity will retain the name "Keystone Dental."
                                
Michael Kehoe is the President and Chief Executive Officer (CEO) of the 
newly merged company and the former CEO of Southern Implants.  Mr. Kehoe
 has a keen understanding of the oral healthcare sector from his years 
of experience at Southern Implants and previously as Founder and CEO of 
Innova Lifesciences Corporation (now a part of the Danaher Corporation).
  The new management team will be comprised of individuals from both 
Keystone and Southern Implants.
                                
"The merger of Keystone Dental and Southern Implants represents an 
excellent strategic fit for the two companies," said Michael Kehoe, new 
President and CEO of Keystone Dental.  "The combination of Keystone's 
portfolio of industry-proven biomaterials and dental implants with 
Southern's unique dental implant systems for both the esthetic zone and 
molar regions provides the merged company with a greatly expanded 
product range for the dental implant community."
                                
"This merger will strongly reinforce each company's existing presence in
 the U.S. and in other international markets. Beyond the great 
technology combination, it will provide a unique addition of talent in 
management, product development, sales and customer support, added to a 
long combined dental experience," said Pascal Girin, former CEO of 
Keystone Dental and now a board member of the merged company.
                                
The company will maintain headquarters in Burlington, MA and will 
continue to operate its other manufacturing facility in Irvine, CA.
                                
About Keystone DentalKeystone Dental is an oral healthcare company 
dedicated to the delivery of breakthrough technology. Headquartered in 
Burlington, Massachusetts, Keystone Dental's product portfolio includes 
Genesis, The Biomimetic Implant System(TM), The Prima(TM) Implant 
System, DynaMatrix® Extracellular Membrane, DynaBlast® and DynaGraft® 
bone graft substitutes, and Accell Connexus(TM), a next-generation 
bioactive bone grafting product.
                                
Launched in 2006 by Warburg Pincus, a leading global private equity firm
 focused on growth investing, Keystone Dental represents the 
continuation of the business of Lifecore Biomedical, a participant in 
the dental implant market since 1990. Keystone Dental's vision is to be a
 trusted oral healthcare partner focused on breakthrough technologies, 
whose goal is to inspire customers, instill pride in its employees, and 
deliver value every day.
                                
About Southern ImplantsSouthern Implants was established in 2006 to 
commercialize in North America, South America and Asia, dental implant 
technologies that have been sold in Europe and other parts of the world 
for over two decades. Southern Implants, with headquarters in Irvine, 
California, provides implant surgeons and restorative dentists with a 
broad range of implants and restorative components that work seamlessly 
with existing systems while offering unique, innovative features that 
simplify even the most complex clinical challenges.
                                
Southern Implants' proprietary products, the MAX and Co-Axis implant 
systems provide unique therapies which will enable the merged company to
 differentiate itself competitively and to grow within this large and 
expanding market. In addition, Southern Implants manufactures a complete
 line of generic implants.
                                
The MAX Implant is an FDA-cleared implant for immediate placement and 
immediate load in a molar extraction socket. The Co-Axis Implant is the 
only implant on the market with 12 degree and 24 degree angle 
incorporated into the implant for multiple applications.
                                
Comments